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The retinoblastoma protein (pRb) is a central regulator of the cell cycle, controlling passage through G1 phase. Moreover, pRb has also been
shown to play a direct role in the differentiation of multiple tissues, including nerve and muscle. Rb null mice display embryonic lethality,
although recent data have indicated that at least some of these defects are due to placental insufficiency. To investigate this further, we have
examined the role of pRb in early development of the frog Xenopus laevis, which develops without the need for a placenta. Surprisingly, we see
that loss of pXRb has no effect on either cell cycling or differentiation of neural or muscle tissue, while overexpression of pXRb similarly has no
effects. We demonstrate that, in fact, pXRb is maintained in a hyperphosphorylated and therefore inactive state early in development. Therefore,
Rb protein is not required for cell cycle control or differentiation in early embryos, indicating unusual control of these G1/G0 events at this
developmental stage.
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The retinoblastoma protein (pRb) plays a central role in
controlling passage through the cell cycle (Sherr, 1996)
primarily by regulating the activity of E2F transcription factors
(Dyson, 1998). At its simplest level, during early G1 phase, pRb
is hypophosphorylated, allowing it to bind and inactivate E2Fs,
thus preventing the expression of E2F target genes (Flemington
et al., 1993), many of which are required for DNA synthesis
(Muller et al., 2001). Late in G1, mitogenic signals such as
growth factors promote the progressive hyperphosphorylation
of pRb by cyclin D/CDK4 and 6 and cyclin E/CDK2, resulting
in E2F release, activation of E2F target genes and progression
into S phase (Sherr, 2000).
pRb also plays a direct role in tissue differentiation, which
has been best described in myogenesis. pRb has two functions⁎ Corresponding author.
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doi:10.1016/j.ydbio.2006.11.015in terminal muscle differentiation: firstly, it is required to arrest
the cell cycle by inhibiting E2F activity; secondly, its direct
interaction with the muscle determination factor MyoD is
required for the full transcriptional activity of the muscle
differentiation factor MEF2. MEF2, in turn, induces expression
of myosin heavy chain and muscle creatine kinase and the fully
differentiated myocyte phenotype (Novitch et al., 1996;
Novitch et al., 1999).
The ability of pRb to cause cell cycle arrest depends on its
binding both E2Fs and DNA. However, its ability to promote
differentiation by co-operation with transcription factors such as
MyoD may be independent of E2F/DNA complex formation
(Sellers et al., 1998). pRb plays a similar role in the differ-
entiation of several other tissues, for example in adipogenesis
(Chen et al., 1996), monocyte/macrophage differentiation (Chen
et al., 1996), osteogenesis (Thomas et al., 2001) and epidermal
differentiation (Nead et al., 1998; Ruiz et al., 2004). Thus, the
promotion of terminal differentiation by pRb is not merely a
consequence of its induction of cell cycle exit and, as a protein
with two separable but complementary functions, pRb is well
placed to co-ordinate these events.
312 R.A. Cosgrove, A. Philpott / Developmental Biology 303 (2007) 311–324There are several lines of evidence which suggest that pRb
performs a specific function in the differentiation of neural cells.
Firstly, the most common cancer resulting from the loss of Rb is
retinoblastoma, which originates from the neuroepithelial cells
of the developing retina (Friend et al., 1986). This contrasts with
the wide range of tumours that bear mutations in the genes of
other members of the Rb pathway. Secondly, the level of Rb
transcription is highest prior to and during the differentiation
processes of neurogenesis, haematopoiesis, myogenesis, lens
development and in the ganglion cell layer of the embryonic
retina in mice (Jiang et al., 1997). In addition, there are distinct
regulatory elements in the Rb promoter that are sufficient to
direct expression of a fused transgene exclusively to the central
and peripheral nervous systems (Jiang et al., 2001). The effect of
overexpressing pRb in cultured cells supports the hypothesis that
its activity is not only necessary but also sufficient to induce
neural differentiation: CDK activities decline and pRb phos-
phorylation is consequently lost during experimentally induced
differentiation of neuroblastoma cells, and overexpression of
either the CDKI p27Kip1 or of pRb itself is sufficient to induce
neuronal differentiation in these cells (Kranenburg et al., 1995).
These observations suggest that pRb may function as a
determinant of neuronal differentiation. Recently, a role for
pRb has been described as a coactivator of NeuroD1 transcrip-
tional activity in mammalian cells (Batsche et al., 2005),
although the factors responsible for the expression of Rb in the
nervous system have not been identified.
A role for pRb in the development of several embryonic
tissues was suggested from analysis of Rb null mice. Mice
that express no functional pRb die between gestational days
14 and 15 exhibiting major developmental defects in the
central nervous and haematopoietic systems, which show
evidence of ectopic mitoses and massive cell death (Clarke et
al., 1992; Jacks et al., 1992; Lee et al., 1992). However,
intriguingly, much of the Rb null phenotype can be rescued by
supplying Rb−/− embryos with wild-type placentae (Wu et
al., 2003). Loss of pRb causes excessive proliferation of
trophoblast cells and results in their failure to differentiate,
leading to severe disruption of the structure of the placental
labyrinth. This results in decreased vascularisation and
significant impairment of placental transport function. Most
of the neurological and erythroid abnormalities seen in Rb
null embryos are therefore secondary to the effect of Rb loss
on placental tissue (Wu et al., 2003).
Rb null embryos rescued by wild-type placentae survive until
birth, when they die of skeletal muscle defects (de Bruin et al.,
2003). These rescued embryos exhibit increased DNA replica-
tion and cell division in the CNS, similar to the phenotype of Rb
knockout embryos. However, they do not show the widespread
neuronal apoptosis which contributes to the lethality caused by
Rb loss when the placenta is also Rb−/−. This indicates that the
function of pRb in extra-embryonic lineages plays an important
role in the suppression of apoptosis of neuronal cells, but not in
the regulation of neuronal division and differentiation (de Bruin
et al., 2003). However, to study the role of pRb in the earliest
stages of vertebrate nerve and muscle differentiation, it would
be helpful to turn to an organism in which embryos developoutside the mother, for instance those of the frog Xenopus
laevis.
The Xenopus homologue of the retinoblastoma gene (XRb)
shows 56% sequence homology with human and murine Rb at
the amino acid level and is highly conserved in many
functionally important regions (Destree et al., 1992). Maternal
transcripts of XRb are highly represented in oocytes, while XRb
protein levels increase tenfold between the unfertilised egg
stage and stage 7.5 and then remain constant until stage 11.5.
Zygotic transcription of the XRb gene is initiated at stage 13,
and persists throughout early development and in all examined
tissues of the adult frog, but expression levels vary greatly
between tissues (Destree et al., 1992).
A study of Xenopus E2F revealed that the majority of E2F
DNA binding activity exists in the free, uncomplexed form in
the egg and throughout early embryogenesis (Philpott and
Friend, 1994). Indeed, Xenopus E2F only begins to form
complexes visible by gel retardation assay, and presumed to
be with XRb, at neural plate stage 17 (Philpott and Friend,
1994). While more sensitive detection of E2F binding proteins
revealed that XRb can bind E2F in the very early embryo,
XRb is found only at a very low level at these early stages
(Destree et al., 1992). Moreover, at this time only a small
proportion of XRb binds E2F, leaving E2F predominantly
uncomplexed until at least stage 35, although analysis of
Xenopus tissue culture cells revealed significant E2F-XRb
complexing by metamorphosis (Philpott and Friend, 1994).
Here, we have investigated the role of XRb in regulation of
both cell cycling and differentiation during early development.
XRb is expressed most highly in developing neural tissue of
Xenopus embryos. However, surprisingly we find that modula-
tion of the levels of XRb protein, by either depletion or
overexpression, does not perturb cell cycle regulation, nor the
differentiation of nerve or muscle tissue. These observations
may be explained by the predominantly hyperphosphorylated,
i.e., inactive status of pXRb that we detect throughout early
Xenopus embryogenesis. Thus, pXRb is subject to develop-
mental control, but is not essential for the early stages of
development of Xenopus, perhaps representing fundamental
differences in regulation of cell division and differentiation at
early versus late developmental stages.
Results
Expression pattern of XRb in the early Xenopus embryo
It is becoming increasingly apparent that genes that
regulate the cell cycle are not always expressed at equal
levels in all proliferating cells, which may indicate additional
functions in the development and differentiation of different
tissues (Vernon and Philpott, 2003). To determine the
developmental expression of XRb in the early Xenopus
embryo, we performed whole mount in situ hybridisation to
detect mRNA transcripts (Fig. 1). While XRb is barely
detectable before neural plate stages (R. Cosgrove, A. Vernon,
A. Philpott, unpublished data), expression becomes visible in
the neural plate and anterior placodal regions including the eye
Fig. 1. Expression pattern of the Xenopus retinoblastoma gene. XRb expression was analysed by whole mount in situ hybridisation (stained in purple) in embryos at a
range of stages. XRb is expressed in the anterior placodes (P) from stage 16 and increases by stage 19, especially in the optic vesicles (OV). Between stages 26 and 30,
strong expression is seen in the optic vesicles, neural tube (NT) and branchial arches (BA). (A) Stage 16, anterior view; (B) stage 19, anterior view; (C) stage 26, lateral
view; (D) stage 28, dorsal view; (E) stage 30, lateral view. Anteriors to the right (C, D, E).
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expressed in the anterior placodes (P) and optic vesicle (OV),
as well as in the developing neural tube (NT) (Fig. 1B). As
development progresses, staining intensifies in the eye, brain
and neural tube, as well as in the branchial arches (BA) (Figs.
1C, D, E). Interestingly, while the role of pRb in the regulation
of skeletal myogenesis has been well documented in
mammalian cultured cell systems (Novitch et al., 1999;
Sellers et al., 1998), XRb is not highly expressed in the
myotome. Therefore, although XRb transcripts were detected
throughout early Xenopus embryogenesis and in all adult
tissues examined (Destree et al., 1992), its expression is
greatly upregulated in developing neural tissues during the
period when primary and secondary neurogenesis occurs
(Hartenstein, 1989). This elevated neural expression is
consistent with a conserved function of pRb in vertebrate
neural tissues (Batsche et al., 2005; Jiang et al., 1997, 2001;
Kranenburg et al., 1995), although its absence from the
developing myotome is of note.
Depletion of pXRb from the early embryo
In order to investigate the effect of loss of XRb protein in
developing Xenopus embryos, we microinjected an antisense
morpholino oligonucleotide (Mo) targeted at the translational
start site of XRb mRNA (XRb Mo), which should prevent
translation of XRb protein (Heasman, 2002). To determine the
effect on XRb protein expression, XRb Mo or a control
morpholino (Con Mo) was injected into both blastomeres of
two-cell stage embryos, and these were subsequently allowed to
develop up to tailbud stage 22. Extracts were prepared from
embryos at three stages and Western blotted for XRb protein
(Fig. 2A). XRb Mo completely blocked translation of endogen-ous pXRb at stages 10, 15 and 22. In contrast, pXRb was still
present after injection of Con Mo.
XRb protein is not essential for cell cycle progression during
early embryogenesis
Awealth of evidence has implicated pRb in the regulation of
the cell cycle (de Bruin et al., 2003; Sherr, 2000; Weinberg,
1995). Moreover, by the time of their death between gestational
days 14 and 15, the phenotype of Rb null mice shows evidence
of major cell cycle dysregulation, specifically ectopic mitoses
and massive apoptosis, which causes developmental defects in
the nervous and haematopoietic systems (Clarke et al., 1992;
Jacks et al., 1992; Lee et al., 1992). However, more recently it
has been established that some of these effects may result from
placental defects in Rb null mice (de Bruin et al., 2003; Wu
et al., 2003). As Xenopus embryos develop externally, we have
investigated whether loss of XRb perturbs cell cycle regulation
during early embryogenesis in the absence of a placental
requirement. To this end, XRb protein was depleted by injecting
the XRb Mo into one dorsal blastomere at the four-cell stage to
target the morpholino to the developing nervous system where
XRb is most highly expressed (Fig. 1). As the first plane of
cleavage determines bilateral symmetry within the embryo,
morpholino injected in this way is incorporated unilaterally
within the neural tube, while the uninjected side of the embryo
acts as an internal control. Embryos were allowed to develop to
stage 21 before serial sectioning and immunostaining for
phosphorylated histone H3 (pH3), a marker of mitotic cell
proliferation (Saka and Smith, 2001), used to detect effects of
pXRb depletion on cell cycling in the neural tube (Fig. 2B).
Surprisingly, XRb Mo had no significant effect on cell
proliferation when comparing the injected and uninjected sides
Fig. 2. XRbmorpholino specifically depletes XRbprotein but does not affect the number of cells inmitosis or S phase in the neural tube, or the number of cells undergoing
apoptosis or S phase in the epidermis. (A) Embryos were injectedwith 20 ngXRbmorpholino (Mo) or controlMo in both blastomeres at the two-cell stage. Extracts made
from these embryos at stages 10, 15 and 22 wereWestern blotted and probed with anti-Rb antibody (XZ160). The same blot was stripped and probed with an anti-β-actin
antibody to show equal loading. XRbMo depletes XRb protein at all three stages, while control Mo does not affect its level. (B) Embryos were injected with 20 ng XRb
Mo and β-galactosidase as a tracer (visible as green autofluorescence) in one dorsal cell at the four-cell stage. At stage 21, embryos were sectioned and immunostained
using an anti-phospho histone H3 antibody to visualise mitotic cells (red fluorescence) in the neural tube (NT). Hoechst staining of nuclei (blue). (C) Embryos were
injected in one cell at the two-cell stagewith 20 ngXRbMo (Ca–Cc) or controlMo (Cd–Cf) andβ-galactosidase as a tracer (blue) and then injectedwith BrdU at stage 20.
After 2 h they were fixed and epidermal cells in S phase were visualised by whole mount BrdU immunostaining (purple). There is no difference between the density of
cells in S phase in theMo-injected sides of the embryos (Ca andCd) and their density in the uninjected sides of the same representative embryos (Cc andCf). Dorsal views
with injected sides on the left and uninjected sides on the right (Cb andCe). (D) Embryoswere injectedwith 20 ngXRbMo,with or without subsequent BrdU injection (as
in C), sectioned and immunostained with anti-phospho histone H3 or anti-BrdU antibody. The numbers of cells in mitosis or S phase in both injected and uninjected sides
of the neural tubes were counted in serial sections (n=6 embryos for each marker, average of 41 sections per embryo). Average percentage differences between the sides
are shown, with error bars showing the standard errors. pXRb depletion results in no significant change in the number ofmitotic cells on the injected side of the neural tube
compared to the uninjected side (average 8% increase, p=0.2), or in the number of cells in S phase (average 28% increase, p=0.43). (E) Embryos injectedwith 20 ngXRb
Mo (Ea and Eb) or control Mo (Ec and Ed) with β-galactosidase as a tracer (blue) in one cell at the two-cell stage were fixed at stage 22. Apoptotic cells in the epidermis
were visualised bywholemount TUNEL staining (purple). (F) The numbers of TUNEL-stained cells were counted in sample areas on both theMo-injected and uninjected
sides. Average percentage differences between the sides are shown, with error bars showing the standard errors. Neither XRb Mo (p=0.44; n=10) nor control Mo
injection (p=0.1; n=11) affects the number of apoptotic cells in the epidermis (cf. injected sides, Ea and Ec, with uninjected sides, Eb and Ed).
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per embryo; p=0.2) and compared to the Con Mo-injected
control (data not shown), indicating that pXRb is not essential
for regulation of cell proliferation at this stage, even in the neural
tube where it is most highly expressed.
XRb is most highly expressed in the nervous system, as
detected by in situ hybridisation (Fig. 1), yet it may be expressed
in other tissues at a lower level, and indeed can be detected in
ectodermal explants (animal caps) that have differentiated into
atypical epidermis, by RT-PCR (data not shown). While pRb is
widely expressed in mice, it is not expressed at the same level in
all cell types: for example, pRb protein levels are elevated in the
brain and liver (Bernards et al., 1989; Szekely et al., 1992).
Therefore, the effect of pXRb depletion on mitosis in the
epidermis was also analysed by injection of XRb Mo (or Con
Mo) into one cell of a two-cell embryo followed by phospho-
histone H3 immunostaining. The numbers of mitotic cells in
sample areas on the flank of injected and uninjected sides of a
series of injected embryos were considerably higher than those
seen in the neural tube and were counted. As expected, as pRb is
only expressed endogenously at a low level in the epidermis,
analysis showed that XRb depletion caused no significant
change in the number of mitotic cells in the epidermis (data not
shown; p>0.05, n=19).
It is possible that loss of XRb could perturb the cell cycle
prior to mitosis and that this could subsequently result in
apoptosis of these cells rather than a precocious mitotic entry.
To investigate this, we injected XRb Mo or Con Mo into one
cell of two-cell stage embryos. Embryos were fixed at early
tailbud stage and the distribution of cells in S phase was
investigated by staining for bromodeoxyuridine (BrdU) incor-
poration. Firstly, we analysed BrdU incorporation in the neural
tube in embryos injected unilaterally with XRb Mo in sections
(Fig. 2D; n=6 embryos, average 39 sections per embryo). We
saw no significant difference in BrdU incorporation in the
injected versus the uninjected side (Fig. 2D; p=0.43) or when
compared to the Con Mo-injected control (data not shown).
Analysis of BrdU incorporation in the epidermis was also
performed in either XRb Mo-injected embryos (Figs. 2Ca–Cc;
n=20,) or Con Mo-injected embryos (Figs. 2Cd–Cf), and no
significant difference was seen.
Similarly, the number of cells undergoing apoptosis on the
injected versus the uninjected sides of the embryos was analysed
by whole mount TUNEL staining. There was no significant
effect on TUNEL staining after injection of either XRbMo (Figs.
2Ea–b; p=0.44; n=10 embryos) or Con Mo (Figs. 2Ec–d,
p=0.1, n=11 embryos) in the embryonic epidermis (Fig. 2F).
Thus, severe reduction in the levels of XRb did not significantly
affect cell cycle progression in either the neural tube, where it is
expressed at high levels, or in the epidermis, where its expression
is lower. Moreover, loss of XRb did not significantly increase
apoptosis.
XRb protein is not essential for neural or muscle differentiation
Thus unexpectedly, we could not demonstrate a role for XRb
protein in cell cycle regulation in the early Xenopus embryo.Nevertheless, XRb is highly expressed in neural tissue.
Moreover, numerous papers have studied the potential role of
pRb in the regulation of differentiation in a variety of tissues,
including nerve and muscle. In particular, Rb knockout mice
show severe neural defects (Clarke et al., 1992; Jacks et al.,
1992; Lee et al., 1992) and pRb has been demonstrated to play a
direct role in neural differentiation in mice (Lee et al., 1994).
However, the results from Rb knockout mice rescued with
normal placentae shed some doubt on the absolute requirement
for pRb in neurogenesis (de Bruin et al., 2003; Wu et al., 2003).
Thus, we investigated a role for XRb in development and
differentiation of neural tissue in early Xenopus embryos in the
absence of a placental requirement. To this end, embryos were
injected in one blastomere at the two-cell stage with XRb Mo
(or Con Mo), allowed to develop to stage 15 and their
expression of a range of markers of neural differentiation and
patterning analysed by whole mount in situ hybridisation (Fig.
3). The expression of the marker of neural determination
NCAM (Balak et al., 1987), the marker of terminal neural
differentiation neural β-tubulin (Richter et al., 1988) and the
regional neural markers Engrailed (Eizema et al., 1994), Otx2
(Pannese et al., 1995), Pax6 (Hirsch and Harris, 1997) and Xbf1
(Bourguignon et al., 1998), were not affected by XRb protein
depletion (Figs. 3A–F; n=40 per marker). Moreover, no effect
was seen with Con Mo injection (data not shown). Neurite
outgrowth in XRb morpholino-injected embryos at stage 28 was
also examined by whole mount immunostaining with an anti-
neural β-tubulin antibody. Neurites grew normally in both
pXRb-depleted and control sides of the injected embryos (Fig.
3: compare G and H; n=4). These results indicate that XRb
protein does not play an essential role in early stages of
neuralisation, neural differentiation or patterning in Xenopus
embryos.
A direct requirement for the Rb protein in the process of
muscle differentiation, over and above its ability to regulate the
cell cycle, has been demonstrated in cultured cell experiments
(Novitch et al., 1996; Novitch et al., 1999). However, XRb is
not expressed at a high level in the Xenopus myotome (Fig. 1).
Nevertheless, the requirement for XRb protein in myogenesis
was investigated by injecting XRb Mo into one blastomere at
the two-cell stage. The expression of muscle actin, an early
marker of muscle specification, and myosin heavy chain, a
marker of terminal differentiation, were examined by whole
mount in situ hybridisation at stage 15 (Figs. 3I, J). The
expression patterns of these markers of muscle differentiation
were not affected by pXRb protein depletion (n=40 per
marker), indicating that pXRb is not required for muscle
differentiation in Xenopus embryos. Moreover, somites form
normally in XRb Mo-injected embryos, as visualised by β-gal-
expressing nuclei aligning correctly in V-shaped muscle blocks
(Figs. 3G, G′).
In summary, surprisingly, depletion of XRb protein does not
have a significant effect on either cell cycle progression or
differentiation of the Xenopus early embryonic nervous system
or myotome. This may reflect the external development of
Xenopus embryos and strengthens the hypothesis that many of
the phenotypes seen in the Rb null mouse represent problems
Fig. 3. Depletion of XRb protein does not affect neural or muscle differentiation. Embryos were injected in one blastomere at the two-cell stage with 20 ng XRb Mo
with β-galactosidase as a lineage tracer (blue). (A–H) Expression of a range of markers of neural differentiation was examined by in situ hybridisation (stained in
purple) at stage 15. NCAM (A); neural β-tubulin (B); Engrailed (C); Otx2 (D); Pax6 (E); Xbf1 (F). Neurite outgrowth was examined by immunostaining for neural β-
tubulin at stage 28: XRb Mo-injected side (G) and uninjected side (H) of the same embryo; magnified views of the neurites of the same embryo (G′ and H′). Arrow
indicates normal structure of XRb Mo-injected somites (G′). pXRb depletion does not alter the expression patterns of any of these markers. (I, J) Expression of the
markers of muscle differentiation muscle actin (I) and myosin heavy chain (J) was visualised by in situ hybridisation (purple) at stage 15: they are not affected by pXRb
depletion. Dorsal views; anteriors to the right; injected sides uppermost (A, B, I, J). Anterior views; injected sides to the left (C, D, E and F). Lateral views; anterior to
the right (G, G′, H and H′).
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2003). Even if Rb-like functions are essential at these early
embryonic stages of Xenopus development, it is possible that
either enough XRb protein remains after Mo injection, even
though it is undetectable by Western blotting, or that other pRb
family members such as p107 and p130 can substitute for pRbfunctions at this time (Dannenberg et al., 2004; Lee et al., 1996;
Mulligan et al., 1998; Robanus-Maandag et al., 1998; Ruiz
et al., 2004).
A substantial decrease in XRb levels has minimal effects on
early Xenopus development. However, in mice, increasing
absolute amounts of pRb results in a significant decrease in
317R.A. Cosgrove, A. Philpott / Developmental Biology 303 (2007) 311–324body weight (Nikitin et al., 2001), indicating cell cycle
retardation. In addition, Rb overexpression is sufficient to
induce neural differentiation of cultured neuroblastoma cells
(Kranenburg et al., 1995). Consequently, we wanted to
investigate the effects of substantial upregulation in the levels
of XRb protein on early Xenopus development.Fig. 4. Overexpression of XRb does not significantly affect the number of cells in mito
the epidermis. (A) Embryos were injected in both blastomeres at the two-cell stage w
Western blotted and probed with an anti-human pRb antibody (XZ160) that cross-rea
or GFP and β-galactosidase (blue) as a marker in one ventral cell at the four-c
immunostaining (purple) with anti-phospho histone H3 antibody. Dorsal views; anteri
at the four-cell stage with 2 ng XRb mRNA and β-galactosidase (blue), with or witho
anti-phospho histone H3 antibody to visualise mitotic cells or anti-BrdU antibody t
uninjected sides of the neural tubes and the epidermis were counted in serial sections: g
showing standard errors (n=6 embryos for each marker, average of 39 sections per
mitotic cells on the injected side of the neural tube (average 8% decrease; p=0.3) o
phase in the neural tube (average 22% increase; p=0.5) or in the epidermis (average 1
galactosidase (blue) in one cell at the two-cell stage were fixed at stage 22 and apop
(purple). XRb overexpression has no effect on the density of apoptotic cells in the ep
Apoptotic cells were counted in sample areas of the epidermis on both injected and
average percentage difference between the numbers of apoptotic cells on the two sides
errors. XRb overexpression does not make a significant difference to the number o
injection also causes no difference (average 4% decrease; p=0.28; n=10).pXRb overexpression
To investigate the effect of XRb overexpression, XRb
mRNAwas injected into one cell of two-cell stage embryos. A
dose-dependent increase in XRb protein level was detected by
Western blotting of extracts from XRb mRNA-injected embryossis or S phase in the neural tube or epidermis, or the number of apoptotic cells in
ith increasing doses of XRb mRNA. Extracts made from stage 19 embryos were
cts with XRb. (B and C) Embryos were injected with 2 ng mRNA encoding XRb
ell stage. At stage 22 epidermal mitotic cells were stained by whole mount
ors to the right; injected sides uppermost. (D) Embryos injected in one dorsal cell
ut BrdU injection at stage 20, were sectioned and immunostained (purple) using
o visualise cells in S phase. The numbers of positive cells in both injected and
raph shows the average percentage differences between the sides, with error bars
embryo). XRb overexpression causes no significant difference in the number of
r in the epidermis (average 6% decrease; p=0.2), or in the number of cells in S
5% decrease; p=0.1). (E and F) Embryos injected with 2 ng XRb mRNA and β-
totic cells in the epidermis were visualised using whole mount TUNEL staining
idermis: XRb-injected side (E) and uninjected side (F) of the same embryo. (G)
uninjected sides of whole mount TUNEL-stained embryos. Graph shows the
of embryos injected with XRb or GRP mRNA, with error bars showing standard
f apoptotic cells in the epidermis (average 72% increase; p=0.09; n=8); GFP
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persisted until at least stage 19. Injection of 2 ng of XRb mRNA
resulted in significant exogenous expression of XRb protein
compared to the endogenous level without affecting embryo
viability. Hence, we investigated the effect of pXRb over-
expression at this level on cell cycle progression.
Overexpression of XRb protein does not affect cell cycle
progression
Firstly we examined the effect of XRb overexpression on
mitosis as determined by phospho-histone H3 levels in the
neural tube of stage 23 embryos, comparing the uninjected with
the injected sides of the neural tube in the same embryos in
serial sections. This analysis showed that the number of mitotic
cells in the neural tube was not significantly altered by XRb
overexpression (Fig. 4D; p=0.3; n=6, average 38 sections per
embryo).
However, XRb is normally highly expressed in the neural
tube, so further upregulation may have a limited effect. Instead,
we investigated the effect of XRb overexpression in the
epidermis where XRb is usually expressed at a low level.Fig. 5. Overexpression of XRb does not affect neural or muscle differentiation or pat
XRb mRNA and β-galactosidase as a lineage tracer (blue). (A–H) Expression of a
hybridisation (stained in purple) at stage 15. NCAM (A); neural β-tubulin (B); Engrai
The expression patterns of none of these markers were affected by XRb overexpressio
its somites (I′), showing normal somite structure. Arrow indicates normal somite struc
and H). Anterior views; injected sides to the left (D, E and F). Lateral view; anterioNumbers of phospho-histone H3-positive cells were compared
on the flank epidermis of the injected and uninjected sides of
embryos overexpressing XRb, but again XRb overexpression
did not cause a significant difference in the number of cells in
mitosis (Figs. 4B and C; p>0.05; n=15 embryos). We also
analysed the number of pH3-expressing cells in the epidermis in
sections and saw no significant difference in pH3 expression
(Fig. 4D; p=0.2; n=6 embryos, average 38 sections per
embryo). To strengthen this analysis, we also investigated BrdU
incorporation on the injected and uninjected sides of embryos
unilaterally injected with XRb. Early tailbud stage embryos
were sectioned and numbers of BrdU-incorporating cells
analysed (Fig. 4D; p=0.13; n=6, average 39 sections per
embryo). Again there was no difference in proliferation in the
injected versus the uninjected sides.
To determine whether XRb overexpression resulted in an
increase in apoptosis, we also analysed parallel embryos for
apoptotic cells using TUNEL staining. Although there was
some increase in the average number of apoptotic cells on the
XRb-injected side of the embryo compared to the uninjected
side, this was not statistically significant when compared with
GFP-injected embryos (Figs. 4E–G; pXRb overexpression:terning. Embryos were injected in one blastomere at the two-cell stage with 2 ng
range of markers of neural and muscle differentiation was examined by in situ
led (C); Otx2 (D); Pax6 (E); Xbf1 (F); muscle actin (G); myosin heavy chain (H).
n. Lateral view of an XRb-injected embryo at stage 36 (I) and magnified view of
ture (I′). Dorsal views; anterior to the right; injected sides uppermost (A, B, C, G
r to the right (I and I′).
Fig. 6. XRb is predominantly hyperphosphorylated during Xenopus embryo-
genesis. (A) Extracts made from embryos at a range of stages between 1 and 30
were either untreated (−) or treated with lambda phosphatase (λ) and
immunoblotted with anti-Rb antibody (XZ160). Endogenous Rb protein is
detected at all stages between 8 and 30 in its hyperphosphorylated form (upper
bands). (B) Extracts made from embryos at stage 22 (30 μg total protein) or stage
50 (50 μg total protein) were either untreated (−) or treated with lambda
phosphatase (λ) and immunoblotted with anti-Rb antibody (XZ160). pXRb was
predominantly hyperphosphorylated at stage 22 but exists in hyper- and
hypophosphorylated forms at stage 50. (C) Extracts made from uninjected or
XRb mRNA (2 ng)-injected embryos at stage 22 were either untreated (lanes 1
and 3) or treated with lambda phosphatase (lanes 2 and 4) and immunoblotted
with anti-Rb antibody (XZ160). Both endogenous pXRb, seen in uninjected
extracts (lanes 1 and 2), and exogenous pXRb, seen in extracts from XRb-
injected embryos (lanes 3 and 4), are predominantly in the hyperphosphorylated
form (upper bands) at stage 22. Hyperphosphorylated XRb (Hyperphos XRb);
hypophosphorylated XRb (Hypophos XRb); stage (St).
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embryos).
From these analyses, we can conclude that, in early Xenopus
embryos, overexpression of XRb alone is insufficient to perturb
the usual cell cycle regulation of either epidermis or neural
tissue.
Overexpression of XRb protein does not affect muscle
differentiation
The dual functions of arresting the cell cycle and promoting
the transactivation activity of the muscle differentiation factor
MEF2 performed by pRb in skeletal myogenesis in mammalian
cells are well understood, where the effects of upregulation of
pRb levels by transfection were studied (Novitch et al., 1999).
In order to perform these functions, Rb is upregulated prior to
and during muscle differentiation (Jiang et al., 1997). However,
analysis of XRb expression by in situ hybridisation of Xenopus
embryos does not provide any evidence that XRb is upregulated
in the myotome (Fig. 1).
If pXRb is capable of promoting differentiation, its over-
expression might be expected to exert an effect on either cell
cycle exit and/or cell type-specific gene expression in tissues in
which it is endogenously expressed at a low level, such as the
myotome. The effect of pXRb overexpression on muscle
differentiation was therefore examined by injecting embryos in
one blastomere at the two-cell stage with XRb mRNA and β-gal
mRNA as a lineage marker and performing whole mount in situ
hybridisation for the markers of muscle specification and
differentiation, muscle actin and myosin heavy chain, at stage
15. Both of these markers were expressed normally in both the
pXRb-injected sides and the uninjected sides of the embryos
(Figs. 5G, H; n=40 per marker), and embryos developed
normally to later stages. This indicates that pXRb over-
expression does not perturb muscle differentiation in Xenopus
embryos. Moreover, older embryos overexpressing pXRb are
morphologically normal, and fully formed somitic blocks are
clearly visible (Figs. 5I, I′).
Overexpression of XRb protein does not affect neural
differentiation
The role of XRb protein in neural differentiation was also
examined. The expression patterns of the markers of terminal
neural differentiation, neural β-tubulin (NβT) and NCAM,
and of the regional neural markers Engrailed, Otx2, Pax6 and
Xbf1 were visualised by whole mount in situ hybridisation.
They were not affected by pXRb protein overexpression (Figs.
5A–F, n=40 per marker). These results show that pXRb
overexpression perturbs neither neural specification nor
differentiation.
Phosphorylation of pXRb during early embryogenesis
Surprisingly, and in contrast to results found in mammalian
embryos (Bignon et al., 1993; Nikitin et al., 2001), over-
expression of pXRb had no discernable effect on early Xenopusembryogenesis. To ascertain whether exogenous XRb protein
was active, its phosphorylation status was investigated. pRb is
primarily active in binding E2Fs and recruiting chromatin
repressors when it is hypophosphorylated; phosphorylation by
cyclin/CDK complexes inactivates it and prevents its interaction
with E2Fs, allowing E2F-mediated transactivation of targets to
promote cell cycle progression and DNA replication (Sherr,
2000).
In order to determine the phosphorylation status of
exogenous pXRb, embryo extracts from different stages were
treated with lambda phosphatase. Western blots of treated and
untreated XRb-injected embryo extracts showed that XRb
protein first becomes detectable around stage 8. Beyond this, at
all early stages tested, lambda phosphatase treatment caused an
increase in electrophoretic mobility indicative of decreased
molecular weight of endogenous XRb (Fig. 6A). However,
pXRb extracted from considerably older metamorphosing
stage 50 embryos consisted of both a slower and faster
migrating species (Fig. 6B). The fastest migrating pXRb from
stage 50 embryos co-migrates with pXRb from stage 22
embryos that has been treated with lambda phosphatase,
demonstrating that at this late stage of development pXRb
exists in a hyper- and a hypo-phosphorylated form. Moreover,
exogenous pXRb also migrates faster after lambda phosphatase
incubation (Fig. 6C: compare lanes 3 and 4). This result
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in its inactive form in vivo at these stages of development. This
inactivity explains the inactivity of pXRb translated from
injected mRNA and also the apparent dispensability of pXRb
during early Xenopus embryogenesis.
Discussion
Numerous papers over almost 20 years have investigated
the role of pRb in cell cycle progression. While Rb is
expressed in all embryonic and adult tissues examined in the
mouse (Bernards et al., 1989), the level of Rb expression in
mouse tissues varies significantly according to cell type and
differentiation status (Jiang et al., 1997; Szekely et al., 1992).
More recently, it has become apparent that, in addition to
controlling the cell cycle (Weinberg, 1995), pRb has
complementary roles in the regulation of differentiation,
apoptosis (Morgenbesser et al., 1994; Pan and Griep, 1995),
senescence (Dannenberg et al., 2000; Stein et al., 1990) and
maintenance of stem cell identity (Wildwater et al., 2005).
Thus, its expression pattern during development may correlate
with the roles pRb plays in differentiation, firstly to
implement cell cycle arrest (Juan et al., 1998) and secondly
to promote cell type-specific gene expression (Korenjak and
Brehm, 2005; Sellers et al., 1998).
The molecular details of these roles have been primarily
established in cultured cell systems. However, a more
complex situation has been revealed by analysis of pRb
function in vivo by generation of Rb null mice. Classic Rb
knockout mice, in which pRb is missing from both embryonic
and extra-embryonic tissues, show extensive defects particu-
larly in the central nervous and haematopoietic systems, with
resultant widespread apoptosis, leading to lethality around
E14.5 (Clarke et al., 1992; Jacks et al., 1992; Lee et al.,
1992). The hypothesis was proposed that pRb was essential
for correct cell cycle exit and differentiation in these tissues.
However, it was subsequently discovered that pRb is essential
for formation of the placenta. Mice in which Rb has only
been knocked out in the embryonic tissue but where the
placenta is Rb+/+ show essentially normal differentiation of
the central nervous system and haematopoiesis. However,
these embryos still die perinatally, exhibiting severe defects in
skeletal muscle formation (de Bruin et al., 2003; Wu et al.,
2003). Subsequent studies have demonstrated both cell
autonomous and cell non-autonomous functions of pRb
during early mouse development (Maandag et al., 1994;
Williams et al., 1994), but earlier results must now be
reinterpreted in the light of the demonstrated placental
compromise in the Rb null mice.
We were interested in investigating the function of pRb in
early development at initial stages of tissue differentiation, and
to this end have investigated the effects of altered pRb levels on
cell cycle regulation and differentiation of early Xenopus
embryos, which develop outside the mother without requiring
placental function. Initially, we determined the distribution of
XRb transcripts during early embryogenesis by in situ
hybridisation (Fig. 1). XRb is found at very low levels earlyin development. As development progresses, XRb transcripts
accumulate specifically in the central nervous system and the
neural crest, areas where proliferation is high. In contrast, XRb
is undetectable in the myotome. Also, XRb cannot be detected
by in situ hybridisation in the epidermis, but can be seen at low
levels in differentiated animal caps by RT-PCR (data not
shown).
Very early Xenopus cell cycles, prior to the mid-blastula
transition (MBT), consist of alternating S and M phases.
However, after MBT the cell cycle lengthens to incorporate
G1 and G2 phases, and the cell cycle is assumed to more
closely resemble that of mammalian cultured cells (Newport
and Kirschner, 1982). Firstly, we investigated whether
depleting pXRb could alter cell cycling post-MBT by
microinjection of an antisense morpholino oligonucleotide
designed to prevent XRb mRNA translation. This was
achieved very efficiently, with pXRb undetectable by Western
blot at least until tailbud stage 23 (Fig. 2A). Surprisingly,
pXRb depletion had no effect on cell cycling in either the
neural tube (Figs. 2B, D), where pXRb is highly expressed, or
in the epidermis (Fig. 2C), where it is found at lower levels.
Initial analysis was performed by counting cells in mitosis that
expressed phospho-histone H3. However, Drosophila embryos
that have been depleted of the related protein RBF undergo
ectopic S phases, as measured by BrdU incorporation, but
these cells fail to proceed to mitosis, and this is accompanied
by widespread apoptosis (Du and Dyson, 1999). Moreover,
pRb itself has been shown to be a direct regulator of apoptosis
(Morgenbesser et al., 1994; Pan and Griep, 1995). Therefore,
we determined the number of cells incorporating BrdU in the
morpholino-injected side of the neural tube compared to the
uninjected side and again, saw no difference (Figs. 2Ca–f).
Moreover, the number of apoptotic cells, as visualised by
TUNEL staining, was also unaffected (Figs. 2E, F). Thus, loss
of pXRb has no detectable effect on cell cycling or apoptosis
in the early embryo.
The absolute amount of Rb protein has been shown to be
important in mammalian systems, with simple overexpres-
sion resulting in a number of phenotypes. Overexpression of
pRb in mouse embryos results in a decrease in body weight
of between 10 and 30% at gestational day 12.5, when
compared with their wild-type littermates (Nikitin et al.,
2001). This weight reduction is a dose-dependent effect of
Rb overexpression: the degree of dwarfism correlates
roughly with the copy number of the Rb transgene used to
overexpress Rb and the level of Rb protein (Bignon et al.,
1993). Overexpression of Rb in normal cultured cells also
results in growth arrest (Fung et al., 1993). Moreover, the
level of pRb affects the differentiation status of cultured
neuroblastoma cells: Rb overexpression is sufficient to
induce their neural differentiation (Kranenburg et al.,
1995). These results show that growth regulation in early
embryogenesis and the differentiation of some cell types are
sensitive to the absolute amount of pRb available. However,
in Xenopus early embryos, we show that pXRb over-
expression has no effect on cell cycling and little effect on
apoptosis.
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pXRb alter expression of either regional neural markers or markers
of neural differentiation, including the terminal differentiation
marker neural β-tubulin. Again, neither depletion of XRb
protein using morpholinos nor overexpression by mRNA
microinjection resulted in altered expression of either early
markers of regional neural identity such as Engrailed (En) or
Otx2 or markers of early or late neural differentiation (NCAM
and neural β-tubulin respectively) (Figs. 3A–F and 5A–F). Loss
of pRb in primary mouse cell cultures has been shown to affect
neurite outgrowth (Lee et al., 1994). We assayed this in vivo in
Xenopus embryos after XRb Mo injection and again, we saw no
alteration in the pattern of neurites on the injected versus the
uninjected side (Figs. 3G, H).
In mouse embryos, pRb is thought to be particularly
important for skeletal muscle differentiation (Gu et al., 1993).
It has been suggested that pRb and MyoD co-operate to activate
the transcriptional activity of MEF2, as well as to effect
permanent cell cycle withdrawal in myoctyes by upregulating
CDK inhibitor expression (Novitch et al., 1999). Somitic
muscle differentiation in early Xenopus embryos is thought to
occur by analogous pathways, so we investigated whether
differentiation of the myotome, which occurs early in Xenopus
development, is affected by pXRb levels. Neither depletion nor
overexpression of pXRb affected the expression of the early
muscle marker muscle actin or the late marker heavy chain
myosin (Figs. 3I, J and 5G, H). Moreover, embryos that were
allowed to develop to later stages appeared to develop normal
somitic muscle (see β-gal expression in somites formed after
XRb Mo injection, Fig. 3G). Therefore, pXRb does not regulate
somitic muscle differentiation at these stages.
Considering the central role that has been described for
pRb in the regulation of the cell cycle and differentiation in
other species, what are we to make of these results? Rb is a
member of a family of “pocket proteins” consisting of Rb,
p107 and p130 (for a review, see Lipinski and Jacks, 1999). In
mice, p107 and p130 are thought to have partially overlapping
functions and moreover, when Rb is knocked out, its loss can
be partially compensated for by upregulation of p107
(Schneider et al., 1994). Xenopus homologues of p107 and
p130 have not been published, but preliminary investigation
of the genome of the closely related species, Xenopus
tropicalis shows that homologues of both proteins are present
(data not shown). Therefore, it is likely that these may
compensate for the loss of XRb.
Additionally, while our morpholino directed against XRb
appears highly efficient by Western blot analysis, it is possible
that low levels of pXRb remain. However, it is clear that in the
mouse model, absolute levels of pRb are important. Rb null
mice die at E14.5 (Jacks et al., 1992), but the partial rescue of
Rb null mice by Rb expression from a minigene at
approximately 50% of the wild-type level (Zacksenhaus et al.,
1996) shows that a low level of Rb protein is sufficient for the
performance of some, but not all, of pRb's functions. These
mice survive beyond gestational day 14.5, but die at birth with
specific skeletal muscle defects resulting from reduced myoblast
survival and impaired cell cycle withdrawal (Zacksenhaus et al.,1996), indicating that a higher level of pRb is required for the
fulfillment of its role in muscle differentiation than other
functions. Moreover, Rb heterozygous mice expressing Rb at
60% of the wild-type level are 5% larger than their littermates,
while Rb null mice are 15% larger than wild-type at gestational
day 12.5 (Nikitin et al., 2001), demonstrating the importance of
absolute levels of pRb.
We propose that XRb (and potentially other pocket proteins)
are not required for cell cycle regulation or differentiation in
Xenopus at these early embryonic stages. This hypothesis is
supported by three lines of evidence. Firstly, we have
demonstrated previously that Xenopus E2F is present in early
embryos in a form that binds to DNA but does not show
significant complexing to pXRb until stage 17, by gel
retardation assay, and even then pXRb only binds to a very
small proportion of E2F. Moreover, only a single gel-retarded
form of E2F containing pXRb is evident in early embryos, while
E2F activity from cultured XTC cells, derived from much older
metamorphosing Xenopus froglets, is composed of free E2F
and two slower migrating forms (Philpott and Friend, 1994).
Thus, in early embryos, E2F complexes are more simple than
those found in cells derived from older frogs.
Secondly, active pRb, which interacts with E2F and other
factors to regulate passage through G1 phase, cell cycle exit and
differentiation, is known to be hypophosphorylated (Weinberg,
1995). In contrast, we demonstrate here that the overwhelming
majority of pXRb at early embryonic stages is hyperphos-
phorylated (Fig. 6). This is not only true for endogenous pXRb
but also for overexpressed pXRb. Therefore, at least until stage
30, pXRb is primarily maintained in an inactive form, again
indicating that it is not essential for cell cycle progression or
differentiation at these stages of development, and this would
explain why upregulation or downregulation of pXRb levels has
no developmental effect early on.
Thirdly, in mouse embryos it has been clearly shown that
there is a cell-autonomous requirement for pRb in differentia-
tion of muscle (Gu et al., 1993). Interestingly, not only is pRb
required for stable cell cycle exit in this tissue (Novitch et al.,
1996), but it must also co-operate with MyoD to bring about the
full programme of muscle differentiation, possibly by promot-
ing activity of the transcription factor MEF2 (Novitch et al.,
1999). Perhaps surprisingly, considering the wealth of data
demonstrating a role for pRb in muscle differentiation, XRb
transcripts are not detected in the developing embryonic
myotome. Moreover, neither early nor late markers of muscle
differentiation are perturbed by either overexpression or loss of
pXRb (Figs. 3I, J and 5G, H). So clearly, at these developmental
stages, muscle differentiation in Xenopus is not regulated by
pXRb levels.
Analyses of Rb null mice have shown that significant defects
become apparent only relatively late in embryonic gestation (for a
review see Lipinski and Jacks, 1999).Moreover, many of themost
dramatic phenotypes that were described originally resulted from
the cell non-autonomous effect of hypoxia induced by placental
defects (Wu et al., 2003). Our data indicate that pXRb is inactive
at early embryonic stages in Xenopus. Inactivity of pRb during
early embryogenesis has also been described in mouse embryos:
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phosphorylated, with the hypophosphorylated form only appear-
ing in significant amounts later on (Paggi et al., 1996). In mouse
embryonic stem cells, pRb is also found to be mainly
hyperphosphorylated; this has been correlated with their high
rate of proliferation (Savatier et al., 1994). The maintenance of
pRb in its inactive state during early embryogenesis may
therefore facilitate the high level of cell proliferation required for
the rapid growth of young embryos. However, as cells exit the
cell cycle during their progression along the various differentia-
tion pathways, pRb activity might be expected to be required to
regulate the commitment of cells to continued cycling. The
sustained inactivity of pRb during differentiation stages of early
embryos may indicate that other Rb-related proteins are active
during early embryogenesis to promote cell cycle exit and
differentiation, although alternative regulatory pathways are also
possible. However, it is clear that embryonic cell cycles post-
mid-blastula transition, while adopting the usual G1, S, G2, M
progression, may control the transition between stages somewhat
differently to somatic cells.
Thus, Rb clearly plays a central role in cell cycle regulation
and differentiation of a wide variety of tissues. However, these
roles may vary greatly depending on embryonic stage, activity
of other pocket proteins and mode of development, e.g.,
placental versus non-placental. Our surprising results show that
we must study pRb in the widest possible context if we are to
fully understand its importance in cell cycle regulation and
differentiation in vivo. Moreover, we have much yet to discover
about the unusual ways in which the cell cycle and differentia-
tion are regulated during embryonic development, and must
look to in vivo models to address these questions.
Experimental procedures
Embryos and injections
X. laevis embryos obtained by hormone-induced laying were fertilised in
vitro, dejellied in 2% cysteine, pH 7.8–8.0, washed and incubated in 0.1× MBS.
Embryos were staged according to Nieuwkoop and Faber (1984), fixed in
MEMFA and stained for beta-galactosidase (β-gal: 500 pg–1 ng injected per
embryo as a lineage tracer) as described (Sive et al., 2000). Embryos were
depigmented in 10% H2O2 with 5% formamide and 0.1% SSC in PBS over
bright white light.
The full coding sequence of Xenopus Rb (Destree et al., 1992) was
subcloned into pCS2+ and transcribed using the SP6 Message Machine kit
(Ambion). The sequence of the anti-XRb morpholino was: 5′-
GTTTTCTAGGGCTCTTTGGAGGCAT-3′; and the sequence of the control
morpholino (targeted at a mutant sequence of human β-globin pre-mRNA) was:
5′-CCTCTTACCTCAGTTACAATTTATA-3′ (Gene Tools). Typically 2 ng of
mRNA or 20 ng morpholino was injected into embryos at the two-cell stage in
0.2× MBS supplemented with 4% Ficoll.
Western blotting
Protein extracts were prepared from whole embryos as described (Philpott
and Friend, 1994). Total protein was separated by SDS-PAGE, Western blotted
to nitrocellulose by standard methods and probed for XRb using anti-Rb
antibody XZ160 (Hu et al., 1991) and an HRP-conjugated anti-mouse antibody
(Amersham), or with an anti-β-actin antibody (Abcam) and an HRP-conjugated
rabbit antibody (Jackson Immunoresearch). Antibody binding was detected
using SuperSignal chemiluminescence detection (Pierce).In situ hybridisation, BrdU detection, TUNEL and antibody
staining
Whole mount in situ hybridisation was performed as described (Shimamura
et al., 1994), using the alkaline phosphatase substrate BM purple (Roche).
Linearised plasmids encoding XRb (ClaI/T7), muscle actin (HindIII/T7),
myosin heavy chain (NcoI/SP6), NCAM (ClaI/SP6), neural β-tubulin
(BamHI/T3), Engrailed (XbaI/T3), Otx2 (NotI/T7), Pax6 (NotI/T7) and Xbf1
(XhoI/SP6) were used to generate digoxigenin-labelled (Roche) antisense RNA
probes using the restriction enzymes and RNA polymerases indicated.
BrdU incorporation and detection were performed as described (Hardcastle
and Papalopulu, 2000). Whole mount antibody staining was performed as
described (Sive et al., 2000), using anti-phospho-histone H3 antibody (Upstate)
at 1:500 or anti-neural β-tubulin antibody (JDR 3BS) at 1:350, detected with
alkaline phosphatase-conjugated secondary antibodies (Jackson Immunore-
search and Sigma) using NBT/BCIP (Roche) as substrates. Whole mount
TUNEL staining was performed as described (Hensey and Gautier, 1998).
Embryo sectioning and immunohistochemistry
Embryos were fixed in 4% paraformaldehyde, soaked in 30% sucrose
solution and embedded in OCT medium (Sakura Tissue-Tek) before being
sectioned by cryostat at 10 μm. Mitotic cells in sectioned embryos were
detected using anti-phospho-histone H3 antibody (Upstate; Saka and Smith,
2001), diluted 1:300 and an AlexaFluor-conjugated anti-rabbit secondary
antibody (Molecular Probes). BrdU incorporation was detected using anti-
BrdU antibody (Roche), diluted 1:100 with an AlexaFluor-conjugated anti-
mouse secondary antibody (Molecular Probes). Nuclei were visualised using
Hoechst staining.
Statistical analysis
Statistical analysis was performed using paired t-tests to analyse cell
numbers, comparing the sum of cells counted on the injected and uninjected sides
of all sections of each embryo. We calculated the percentage difference between
the two sides for each embryo, and then calculated the average for the six
embryos of each group, as depicted on the graphs, with error bars showing the
standard errors of the means. For the pH3 analysis, on average 6 pH3-positive
cells per embryo were seen in the neural tube and 271 pH3-positive cells were
seen in the epidermis. For BrdU analysis, on average 25 positive cells were seen
in the neural tube per embryo and 1243 positive cells were seen in the epidermis.
λ-phosphatase treatment of embryo extracts
Embryo extracts were incubated with 100 units λ-phosphatase (NEB) in λ-
PPase buffer (NEB) with 2 mMMnCl2 for 3 h at 30°C and then electrophoresed
by SDS-PAGE prior to Western blotting.Acknowledgments
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